Cost Plus Drugs Review
Best for: the cheapest transparent-pricing brand-name Ozempic channel
Mark Cuban's transparent-pricing online pharmacy. Sells branded Ozempic at the wholesale acquisition cost plus 15% markup plus a flat $5 pharmacy fee — publicly disclosed margin formula. Pharmacy fulfillment only; no telehealth intake. Ships to all 50 states. Distinct from telehealth platforms that route brand-name semaglutide through similar discount channels.
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Cost Plus Drugs offers the broadest state availability and easiest access.
Cost Plus Drugs at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Ozempic
- Starting price
- $279/mo
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Cost Plus Drugs
Each dimension is scored algorithmically from Cost Plus Drugs’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.0/10At $279/mo, Cost Plus Drugs runs about 65% above the $169 median for GLP-1 providers.
Effectiveness25%
9.6/10Cost Plus Drugs offers semaglutide, the GLP-1 with the deepest published weight-loss evidence base. FDA-approved brand options are available alongside compounded versions.
User Experience15%
8.6/10Online intake and platform experience; 5 platform features disclosed.
Trust & Safety15%
8.7/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-05).
Accessibility10%
10.0/10Cost Plus Drugs treats patients in all 50 states. Insurance pathways are offered for eligible patients.
Support10%
7.6/10Cost Plus Drugs provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Cost Plus Drugs review
Last checked 2026-06-05- Confirmed current pricing across 1 dose/plan tier
- Confirmed availability in all 50 states
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Cost Plus Drugs offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check Cost Plus Drugs's current pricing and active discounts before you decide.
What we like
- Transparent pricing: wholesale cost + 15% markup + $5 pharmacy fee, the same for everyone
- Around $279/mo for branded Ozempic — well below typical retail list prices
- Mark Cuban's PBM-disrupting pharmacy, praised by Forbes Health, Wired, and KFF Health News
- Ships to all 50 states; genuine FDA-approved Novo Nordisk Ozempic, not compounded
- Partnered with 9amHealth so you can get prescribed and fill at Cost Plus pricing
Watch-outs
- Fulfillment only — no telehealth intake; you need a prescription from an outside clinician
- Ozempic is FDA-indicated for type 2 diabetes, not weight management — weight-loss use is off-label
- Wegovy availability has been spotty — check current stock before assuming it ships
- No compounded semaglutide or tirzepatide — brand only
- No clinical follow-up — side-effect monitoring falls to your prescribing clinician
Cost Plus Drugs is a pharmacy, not a weight-loss program
The first thing to understand about Mark Cuban's Cost Plus Drugs is what it is not. It is not a telehealth clinic, it does not have doctors who will see you, and it will not write you a prescription. It is a mail-order pharmacy that fills prescriptions other clinicians write. If you already have a valid prescription for brand-name Ozempic in hand, this is one of the cheapest, most transparent places in the country to fill it. If you are starting from zero and need someone to evaluate you and prescribe, Cost Plus Drugs alone will not get you there.
That single distinction decides whether this provider is right for you. Read the verdict below with that framing in mind, because everything else about Cost Plus Drugs flows from its fulfillment-only model.
The pricing formula is the whole point
Most pharmacies treat their markup as a trade secret. Cost Plus Drugs does the opposite and publishes the exact math on every product: the manufacturer's wholesale acquisition cost, plus a flat fifteen percent markup, plus a five-dollar pharmacy fee, plus shipping. That formula is the company's entire reason for existing — Cuban founded it in 2022 to route around the pharmacy-benefit-manager middlemen who quietly inflate drug prices.
For branded Ozempic, that works out to roughly $279 a month at the time of writing. That is well below the typical retail list price, where brand-name semaglutide can run over a thousand dollars a month without insurance. It is higher than the category median of $169 a month, but that comparison is a little unfair: the median is dominated by compounded products, and Cost Plus is dispensing genuine, FDA-approved Novo Nordisk Ozempic, not a compounded copy. You are paying for the real brand at a near-wholesale price.
One honest caveat on the number: the $279 figure is derived from the publicly disclosed formula and Ozempic's wholesale cost, and a live storefront price can move when the underlying wholesale cost moves. Because the formula is fixed and public, you can always check the current SKU price yourself before you order — and you should.
Brand Ozempic only — no compounds, no shortcuts
Cost Plus Drugs dispenses brand-name Ozempic, the FDA-approved injectable from Novo Nordisk. There is no compounded semaglutide here and no tirzepatide at all. For people who specifically want the brand product and are wary of the compounding gray market, that is a genuine selling point — you know exactly what you are getting.
Two things worth flagging. First, Ozempic is FDA-indicated for type 2 diabetes, not weight management; using it purely for weight loss is off-label, which is a conversation to have with your prescriber. Second, Wegovy — the version of semaglutide that is actually approved for weight loss — has had spotty availability through this channel, so do not assume it ships. Check current stock before you build a plan around it.
How people actually use it: bring your own prescription
Because there is no intake here, the practical workflow is: get evaluated and prescribed somewhere else, then send the prescription to Cost Plus Drugs to fill at its transparent price. To smooth that path, Cost Plus partnered with the telehealth provider 9amHealth in 2025, so you can be prescribed on the clinical side and fill at Cost Plus pricing. If you have an existing relationship with a primary-care doctor or endocrinologist, they can send a prescription directly.
- Already have a prescription? This is close to an ideal fill option — cheap, transparent, ships to all 50 states.
- Need to be prescribed? You will need an outside clinician (your own doctor or a telehealth partner like 9amHealth) first.
- Want clinical follow-up and side-effect monitoring? That responsibility sits entirely with your prescriber, not the pharmacy.
Trust and oversight: legitimate, but only as a pharmacy
On the trust side, Cost Plus Drugs is on solid ground. It is a national mail-order pharmacy dispensing genuine FDA-approved product, with no FDA warning letters on file in our records. The transparent-pricing model has been covered favorably by Forbes Health, Wired, and KFF Health News, and the company is one of the more visible attempts to disrupt opaque drug pricing in the U.S.
But oversight here means pharmacy oversight, not medical oversight. There is no clinical team checking in on how the medication is working for you, no dose-titration support, and no one watching for side effects. With a GLP-1 medication, where nausea and dose ramp-up genuinely matter, that monitoring has to come from whoever wrote your prescription. Going in expecting a managed program would be a mistake.
Who should choose it, and who should skip it
Choose Cost Plus Drugs if you want brand-name Ozempic at the most transparent price you can find, you already have or can easily get a prescription, and you are comfortable managing the clinical side through your own doctor. The honesty of the pricing formula alone makes it worth a look for anyone paying cash.
Skip it — or pair it with a telehealth service — if you need someone to prescribe for you, you want compounded semaglutide or tirzepatide to save more money, or you want ongoing clinical support baked into the price. For those needs, a full telehealth platform that handles intake, prescribing, and monitoring will serve you better, even if the headline price is higher. You can see how we weigh these trade-offs in our scoring methodology.
Bottom line
Cost Plus Drugs is the most honest pricing in the room, but it only solves half the problem. As a fill-only pharmacy for genuine brand Ozempic at roughly $279 a month, it is hard to beat on transparency and value. Just remember it is a pharmacy, not a clinic — bring your own prescriber, confirm current stock and pricing on the live storefront, and you will know exactly what you are paying and why.
Ready to start with Cost Plus Drugs?
Starting at $279/month. See current pricing and start your free consultation.
Alternatives to Cost Plus Drugs
Editorial score · methodology
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Cost Plus Drugs review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Ready to start with Cost Plus Drugs?
Starting at $279/month. See current pricing and start your free consultation.